AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionD.B. Root & Company, LLC
Latest Disclosed Ownership1,328 shares
Latest Disclosed Value $ 288,827
D.B. Root & Company, LLC reports 11.04% increase in ownership of 4AB / AbbVie Inc.

On May 12, 2026 - D.B. Root & Company, LLC filed a 13F-HR form disclosing ownership of 1,328 shares of AbbVie Inc. (DE:4AB) valued at $246,211 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 1,196 shares of AbbVie Inc.. This represents a change in shares of 11.04% during the quarter. The current value of the position is $250,328 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE COM 00287Y109 1,328 132 11.04 289 5.49 0.0690
2026-02-03 2025-12-31 13F ABBVIE COM 00287Y109 1,196 44 3.82 273 2.63 0.0667
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 1,152 47 4.25 267 29.76 0.0677
2025-07-22 2025-06-30 13F ABBVIE COM 00287Y109 1,105 -14 -1.25 205 -12.39 0.0606
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 1,119 1,119 234 0.0757
2023-07-18 2023-06-30 13F ABBVIE COM 00287Y109 0 -10,458 -100.00 0 -100.00
2023-04-18 2023-03-31 13F ABBVIE COM 00287Y109 10,458 423 4.22 1,667 2.78 0.6558
2023-01-27 2022-12-31 13F ABBVIE COM 00287Y109 10,035 55 0.55 1,622 21.06 0.6852
2022-10-26 2022-09-30 13F AbbVie COM 00287Y109 9,980 -267 -2.61 1,339 -14.66 0.6097
2022-07-21 2022-06-30 13F AbbVie COM 00287Y109 10,247 74 0.73 1,569 -4.85 0.6729
2022-05-06 2022-03-31 13F AbbVie COM 00287Y109 10,173 98 0.97 1,649 20.89 0.6139
2022-02-01 2021-12-31 13F AbbVie COM 00287Y109 10,075 -577 -5.42 1,364 18.71 0.4919
2021-10-22 2021-09-30 13F AbbVie COM 00287Y109 10,652 88 0.83 1,149 -3.45 0.4481
2021-07-28 2021-06-30 13F AbbVie COM 00287Y109 10,564 -746 -6.60 1,190 -2.78 0.4444
2021-05-04 2021-03-31 13F AbbVie COM 00287Y109 11,310 1 0.01 1,224 1.07 0.4811
2021-02-09 2020-12-31 13F AbbVie COM 00287Y109 11,309 -701 -5.84 1,211 15.11 0.4835
2020-10-22 2020-09-30 13F AbbVie COM 00287Y109 12,010 -647 -5.11 1,052 -15.30 0.4222
2020-08-06 2020-06-30 13F AbbVie COM 00287Y109 12,657 538 4.44 1,242 34.56 0.5393
2020-04-29 2020-03-31 13F AbbVie COM 00287Y109 12,119 555 4.80 923 -9.78 0.4658
2020-01-14 2019-12-31 13F AbbVie COM 00287Y109 11,564 126 1.10 1,023 18.13 0.4506
2019-10-28 2019-09-30 13F AbbVie COM 00287Y109 11,438 684 6.36 866 10.74 0.4034
2019-07-19 2019-06-30 13F AbbVie COM 00287Y109 10,754 -577 -5.09 782 -14.35 0.3465
2019-04-12 2019-03-31 13F AbbVie Stock 00287Y109 11,331 815 7.75 913 -5.78 0.3897
2019-01-25 2018-12-31 13F/A-1 AbbVie Stock 00287Y109 10,516 146 1.41 969 -1.22 0.4820
2019-01-24 2018-12-31 13F AbbVie Stock 00287Y109 10,370 0 981 0.4322
2018-11-05 2018-09-30 13F AbbVie Stock 00287Y109 10,370 106 1.03 981 3.15 0.4322
2018-07-25 2018-06-30 13F AbbVie Stock 00287Y109 10,264 204 2.03 951 -0.11 0.4488
2018-05-02 2018-03-31 13F AbbVie Stock 00287Y109 10,060 2,118 26.67 952 23.96 0.5027
2018-02-22 2017-12-31 13F ABBVIE COM 00287Y109 7,942 7,942 768 0.6579
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.